AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπ²
Erythromycin Estolate in Zambia
1 product registered with ZAMRA β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Galthrox 125 oral suspension Suspension for Oral Use | 200/026 | GALPHA LABORATORIES LIMITED | active | 2 Jun 2029 |
Erythromycin Estolate β ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Erythromycin Estolate, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Erythromycin Estolate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.